MRKR - Moderna Covid Drug Production Deal And Other News: The Good Bad And Ugly Of Biopharma
Moderna Boosts Production with Lonza Deal
Moderna Therapeutics (MRNA) announced its new collaboration with Lonza for boosting its production capacity for mRNA 1273. The company had recently struck a deal with the federal government to focus on developing COVID 19 vaccine candidate. The company stands to receive $483 million from BARDA for accelerating the development of the vaccine. Moderna dosed the first patient under its Phase I clinical trial in March.
Under the latest deal with the Swiss firm, Moderna will be able to use Lonza manufacturing facilities in the United States and